每經AI快(kuai)訊(xun)，嘉必(bi)優8月20日(ri)晚間(jian)發布公(gong)(gong)(gong)告稱，嘉必(bi)優生物技術(shu)(武漢(han))股(gu)(gu)(gu)份有限公(gong)(gong)(gong)司(si)(si)(si)董事(shi)會(hui)于(yu)近日(ri)收(shou)到(dao)公(gong)(gong)(gong)司(si)(si)(si)董事(shi)長、總經理、實際控制人(ren)易德(de)偉(wei)(wei)先(xian)生“關于(yu)以集中競價交(jiao)易方式回(hui)購公(gong)(gong)(gong)司(si)(si)(si)股(gu)(gu)(gu)份”的(de)提(ti)議。易德(de)偉(wei)(wei)先(xian)生提(ti)議使用公(gong)(gong)(gong)司(si)(si)(si)自(zi)有資(zi)金回(hui)購公(gong)(gong)(gong)司(si)(si)(si)已發行的(de)部分人(ren)民(min)幣普通(tong)股(gu)(gu)(gu)（A股(gu)(gu)(gu)）股(gu)(gu)(gu)票，在(zai)未來(lai)適(shi)宜時(shi)機用于(yu)實施股(gu)(gu)(gu)權激勵(li)計劃。本(ben)次回(hui)購的(de)資(zi)金總額不低(di)于(yu)人(ren)民(min)幣1500萬元（含(han)），不超過人(ren)民(min)幣3000萬元（含(han)）。資(zi)金來(lai)源為公(gong)(gong)(gong)司(si)(si)(si)自(zi)有資(zi)金。

每經頭條（nbdtoutiao）——

(記者 王曉波)

免責聲明：本文內容與數據僅供參考(kao)，不構成(cheng)投(tou)資(zi)建(jian)議，使用前請核實。據此操作，風險自擔。